The European Medicines Agency has recommended marketing authorization for the next version of the Covid-19 vaccine. This time the preparation is updated with protection against Omikron BA.4 and BA.5 virus variants. Meanwhile, doctors are appealing to governments for clear vaccination guidelines. There are still vaccines from the first tranche at the points, and more deliveries are announced in the coming weeks.
EMA's Committee for Human Medicines has recommended approval of an adapted bivalent vaccine against Omikron BA.4 and BA.5 sub-variants.
"This recommendation will further expand the arsenal of vaccines available to protect people from COVID-19 in the face of the ongoing pandemic and anticipated new waves of infection in the cold seaso...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
